"Inside Surgery", The Department of Surgery Newsletter, Summer 2012
UCSF Department of Surgery - August 22, 2012
This issue of Inside Surgery describes several exciting
developments that are advancing our ability to provide outstanding
care for a range of patients including the new Hepatobiliary
Service, under the direction of Carlos
Corvera, M.D., which provides comprehensive,
multidisciplinary care for patients with liver and bile duct
disease. Other topics include updates on Endocrine
Surgery, San Fancisco General Hospital's Wraparound Project, and
notable rankings of our surgeons within U.S. News & World
Report annual update.
Twenty-Five Department of Surgery Faculty Named to U.S. News Top Doctors List
U.S. News - March 01, 2012
In its most recent survey, U.S. News in collaboration
with Castle Connolly Medical Ltd. listed twenty-five (25)
surgeons in the UCSF Department of Surgery, nearly
one-third (1/3) of the clinical faculty, on the list of U.S. News
"Top Doctors". The list, compiled from the opinion of
colleagues, denotes the top 10% of physicians
within a region practicing a given
specialty. Fifteen of the 25 department
surgeons were also named by their peers to the list
of America's Top Doctors (ATD), a
distinction reserved for the top 1% of physicians
in the nation for that specialty.
The listings are published online at U.S. News. The group
rankings are intended to guide patients in selecting a
doctor and physicians in making specialty referrals.
Laura Esserman & Hope Rugo Featured as Pioneers in Breast Cancer Research
UCSF Department of Surgery & PBS Video - March 25, 2011
UCSF breast surgeon Laura J. Esserman, M.D., M.B.A., and
medical oncologist Hope S. Rugo, M.D. are featured on PBS'
"Need to Know" series as pioneers in breast cancer
research. Dr. Esserman discussed the I-SPY 2 TRIAL
in which pharmaceutical companies
collaboratively bring multiple experimental therapies to
the marketplace, allowing numerous combinations novel
agents to be tested in clinical trials iteratively. Specific
drug combinations are personalized to the molecular
characteristics of each patient's tumor using
sophisticated biomarker assays. Dr. Rugo is leading a study to
improve the quality of life in chemotherapy
patients through a new treatment that cools the scalp
and prevents or minimizes hair loss.
"Last October, she (Laura Esserman, MD) and a
urology colleague [Ian Thompson, MD] published an article in the
Journal of the American Medical Association (JAMA) that sounded an
alarm about what she calls "the elephant in the room"- the
rarely-talked-about downsides of routine breast and prostate cancer
screening. Routine mammograms, their article said, find too many
unusual-looking clusters of cells that turn out to be benign,
leading to unnecessary biopsies (and, they argued in a later
editorial, needless anxiety). What's more, all of our intensive
screening efforts result in many women being treated for tumors
that might never have become life-threatening."
SF Chronicle Profiles Dr. Laura Esserman
UCSF News Office - San Francisco Chronicle - July 20, 2009
Laura Esserman, M.D., M.B.A. is
profiled in the San Francisco
Chronicle: her upbringing in Chicago, research and
operatic talents - she sings a patient's requested song as general
anesthesia is being administered. The story also recounts
the story of breast cancer survivor Jessica Galloway, a mother of
three, diagnosed with the disease in 2005; she is now
assisting Esserman in a UCSF peer-support program."
Dr. Laura Esserman (left) meets with patient
Jessica Galloway at UCSF Mt. Zion. Photo provided courtesy
of (Paul Chinn / The SF Chronicle).